Journals / Türk Kardiyoloji Derneği Arşivi / 2005 / Cilt: 33 - Sayı: 6

Classification of patients with ventricular tachycardia according to etiological, demographic and clinical features

Ventrikül taşikardisi olan hastaların etyolojik, demografik ve klinik özelliklere göre sınıflandırılması

Pages
331–340
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In-hospital mortality was significantly higher in patients with diabetes mellitus (p=0.002), acute myocardial infarction (p=0.004), syncope (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We evaluated patients with ventricular tachycardia (VT) with respect to etiological factors, demographic and clinical features, in-hospital mortality and reviewed recent therapeutic approaches in high-risk patients.Study design: This retrospective study included 392 consecutive patients (111 females, 281 males; mean age 59.2 years; range 20 to 90 years) who were admitted to our hospital with sustained VT or who developed in-hospital VT between January 2000 and May 2003.Results: The most common etiological cause was chronic ischemia (45.9%), followed by acute ischemia (18.6%) and dilated cardiomyopathy (14.3%), whereas no etiologic cause was found in 60 patients (15.3%).
📊
Key Findings & Data:Ventricular tachycardia was accompanied by ventricular fibrillation (VF) and syncope in 109 (27.8%) and 196 (50%) patients, respectively.
💡
Conclusion & Impact:In-hospital mortality was significantly higher in patients with diabetes mellitus (p=0.002), acute myocardial infarction (p=0.004), syncope (p
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: We evaluated patients with ventricular tachycardia (VT) with respect to etiological factors, demographic and clinical features, in-hospital mortality and reviewed recent therapeutic approaches in high-risk patients.Study design: This retrospective study included 392 consecutive patients (111 females, 281 males; mean age 59.2 years; range 20 to 90 years) who were admitted to our hospital with sustained VT or who developed in-hospital VT between January 2000 and May 2003.Results: The most common etiological cause was chronic ischemia (45.9%), followed by acute ischemia (18.6%) and dilated cardiomyopathy (14.3%), whereas no etiologic cause was found in 60 patients (15.3%). Ventricular tachycardia was accompanied by ventricular fibrillation (VF) and syncope in 109 (27.8%) and 196 (50%) patients, respectively. Of the patient group, 147 patients (37.5%) had three-vessel, 68 patients (17.4%) had two-vessel, and 35 patients (8.9%) had one-vessel disease. Ninety-two patients (23.5%) died during hospitalization. In-hospital mortality was significantly higher in patients with diabetes mellitus (p=0.002), acute myocardial infarction (p=0.004), syncope (p

Özet

Amaç: Bu çalışmada, ventrikül taşikardisi (VT) olan hastalar etyolojik, demografik, klinik ve hastane içi mortalite açısından değerlendirildi ve yüksek riskli hastalarda yeni tedavi yaklaşımları gözden geçirildi.Çalışma planı: Ocak 2000-Mayıs 2003 tarihleri arasında hastanemize sürekli VT nedeniyle yatırılan ya da izleminde sürekli VT gelişen ardışık 392 hasta (111 kadın, 281 erkek; ort. yaş 59.2; dağılım 20-90) geriye dönük olarak incelendi.Bulgular: Etyolojiye göre sınıflandırmada, en sık nedenin kronik iskemi (%45.9) olduğu, bunu akut iskemi (%18.6) ve dilate kardiyomiyopatinin (%14.3) izlediği görüldü; 60 hastada (%15.3) ise herhangi bir etyolojik neden bulunamadı. Ventrikül taşikardisine 109 hastada (%27.8) ventrikül fibrilasyonu (VF), 196 hastada (%50) senkop eşlik etmekteydi; 147 hastada (%37.5) üç damar, 68’inde (%17.4) iki damar, 35’inde (%8.9) tek damar hastalığı vardı. Hastane içinde ölen hasta sayısı 92 (%23.5) idi. Hastane içi mortalite, diyabetes mellitus (p=0.002), akut miyokard infarktüsü (p=0.004), senkop (p

🔖

Cite This Article

ÖZDEMİR, Ö., SOYLU, M., ATAK, R., KAÇMAZ, F., METİN, F., DEMİR, A. D., ŞENEN, K., SABAH, İ., CİHAN, G., ALYAN, Ö., ARAS, D. (2022). Classification of patients with ventricular tachycardia according to etiological, demographic and clinical features. Türk Kardiyoloji Derneği Arşivi, Cilt: 33 - Sayı: 6, 331–340. https://ajindex.com/articles/633753

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Demirovic J, Myerburg RJ. Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis 1994; 37:39-48
  2. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 1998; 98:2567-73
  3. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2) database. Am J Cardiol 1998;82: 265-71
  4. Volpi A, Cavalli A, Santoro E, Tognoni G. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators. Circulation 1990;82:1279-88
  5. Volpi A, Cavalli A, Franzosi MG, Maggioni A, Mauri F, Santoro E, et al. One year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. Am J Cardiol 1989;63:1174-8
  6. Volpi A, Maggioni A, Franzosi MG, Pampallona S, Mauri F, Tognoni G. In hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med 1987;317: 257-61
  7. Behar S, Reicher-Reiss H, Shechter M, Rabinowitz B, Kaplinsky E, Abinader E, et al. Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. SPRINT Study Group. Am J Cardiol 1993;71:152-6
  8. Behar S, Kishon Y, Reicher-Reiss H, Zion M, Kaplinsky E, Abinader E, et al. Prognosis of early versus late ventricular fibrillation complicating acute myocardial infarction. Int J Cardiol 1994;45:191-8
  9. Berger PB, Ruocco NA, Ryan TJ, Frederick MM, Podrid PJ. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. J Am Coll Cardiol 1993; 22:1773-9
  10. Jensen GV, Torp-Pedersen C, Hildebrandt P, Kober L, Nielsen FE, Melchior T, et al. Does in-hospital ventricular fibrillation affect prognosis after myocardial infarction? Eur Heart J 1997;18:919-24
  11. Nicod P, Gilpin E, Dittrich H, Wright M, Engler R, Rittlemeyer J